# Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)

> **NCT02344225** · PHASE2 · COMPLETED · sponsor: **State University of New York - Downstate Medical Center** · enrollment: 14 (actual)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Caffeine citrate
- **DRUG:** Ibuprofen
- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT02344225
- **Lead sponsor:** State University of New York - Downstate Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2018-06-30
- **Final completion:** 2018-06-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02344225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02344225, "Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02344225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*